Literature DB >> 18513677

Recent advances in cystic fibrosis.

F Ratjen1.   

Abstract

Considerable advances in cystic fibrosis (CF) research have translated into improved patient care, reflected by a continuing trend of improving life expectancy in CF patients. This review summarises some of the major findings of CF research that have occurred in the past year. The review specifically focuses on those developments that have direct implications for patient care or those in which clinical trials suggest benefits that may impact on the treatment of CF patients in the near future.

Entities:  

Mesh:

Year:  2008        PMID: 18513677     DOI: 10.1016/j.prrv.2008.01.004

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  14 in total

1.  Bcl-2 suppresses sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression in cystic fibrosis airways: role in oxidant-mediated cell death.

Authors:  Shama Ahmad; Aftab Ahmad; Elena S Dremina; Victor S Sharov; Xiaoling Guo; Tara N Jones; Joan E Loader; Jason R Tatreau; Anne-Laure Perraud; Christian Schöneich; Scott H Randell; Carl W White
Journal:  Am J Respir Crit Care Med       Date:  2009-02-06       Impact factor: 21.405

2.  The role of mucus in cough research.

Authors:  Bruce K Rubin
Journal:  Lung       Date:  2010-01       Impact factor: 2.584

Review 3.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

4.  When the cystic fibrosis label does not fit: a modified uncertainty theory.

Authors:  Audrey Tluczek; Anne Chevalier McKechnie; Patrice A Lynam
Journal:  Qual Health Res       Date:  2010-02

Review 5.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

6.  Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy.

Authors:  Venizelos Papayannopoulos; Doris Staab; Arturo Zychlinsky
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

7.  Expectorant and antitussive effect of Hedera helix and Rhizoma coptidis extracts mixture.

Authors:  Kee Jae Song; Young-June Shin; Kang Ro Lee; Eun Jung Lee; Yun Suk Suh; Kyung-Su Kim
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

Review 8.  Molecular mechanisms regulating NETosis in infection and disease.

Authors:  Nora Branzk; Venizelos Papayannopoulos
Journal:  Semin Immunopathol       Date:  2013-06-04       Impact factor: 9.623

Review 9.  Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis.

Authors:  John Lam; Steven Vaughan; Michael D Parkins
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2013-11-13

10.  Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.

Authors:  Marieke van Horck; Ariel Alonso; Geertjan Wesseling; Karin de Winter-de Groot; Wim van Aalderen; Han Hendriks; Bjorn Winkens; Ger Rijkers; Quirijn Jöbsis; Edward Dompeling
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.